A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Condition: Non-alcoholic Steatohepatitis (NASH) Interventions: Drug: GB1211; Drug: Placebo Sponsors: Galecto Biotech AB; Covance Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials